Cargando…

Successful Prolonged Desensitization to Epoetin-Alfa Hypersensitivity in an Adult Patient With Advanced Chronic Kidney Disease

The use of erythropoiesis-stimulating agents (ESAs) reduces the need for recurrent blood transfusions in patients with advanced kidney disease. Rarely, allergic reactions to recombinant human erythropoietin can develop, complicating anemia management due to cross-reactivity between these agents. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panchal, Hemali, Ali, Saiyed, Hallett, Rosemary, Young, Brian, Wiegley, Nasim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348604/ https://www.ncbi.nlm.nih.gov/pubmed/37456430 http://dx.doi.org/10.7759/cureus.40424

Ejemplares similares

Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization
por: Huffaker, Michelle F., et al.
Publicado: (2019)

Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease
por: Fishbane, Steven, et al.
Publicado: (2019)

Correction to: Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization.
Publicado: (2020)

Oral Metronidazole Desensitization for Immunoglobulin E (IgE)-Mediated Hypersensitivity
por: Hollis, Chantae C, et al.
Publicado: (2022)

Epoetin Alfa: A Cause of Coronary Artery Thrombosis
por: Siddiqui, Muhammad Umer, et al.
Publicado: (2017)

Iron status and erythropoiesis response to darbepoetin alfa in dogs with chronic kidney disease
por: BHAMARASUTA, Chayanont, et al.
Publicado: (2021)

Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study
por: Santos, E.J.F., et al.
Publicado: (2018)

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial
por: Sörgel, Fritz, et al.
Publicado: (2009)

Successful Desensitization of a Patient with Rituximab Hypersensitivity
por: Ataca, Pinar, et al.
Publicado: (2015)

In vivo suppression of delayed hypersensitivity: prolongation of desensitization in guinea pigs
Publicado: (1975)

Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia
por: Gross, Irwin, et al.
Publicado: (2016)

Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma
por: Khalid, Sidra, et al.
Publicado: (2018)

Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability
por: Arrieta, Javier, et al.
Publicado: (2014)

Ofatumumab Desensitization Protocol: A Case of Refractory Immune Thrombocytopenic Purpura
por: Cochran, Audra L, et al.
Publicado: (2023)

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report
por: Behler, Caroline M, et al.
Publicado: (2009)

Dabbing-Induced Hypersensitivity Pneumonitis
por: Haddad, Ibrahim, et al.
Publicado: (2021)

Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol
por: Lee, Erika Yue, et al.
Publicado: (2021)

Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study
por: Stoppa, Giovanna, et al.
Publicado: (2018)

Successful Management of Prolonged Acute Ischemic Priapism With Penoscrotal Decompression: A Case Report and Review of the Literature
por: Qian, Linda, et al.
Publicado: (2023)

A Sensitive Approach to Managing Hypersensitivity Pneumonitis
por: Ahlawat, Prashant, et al.
Publicado: (2022)

Darbepoetin Versus Epoetin Alfa for the Correction of Anemia in Cancer Patients Receiving Radiotherapy or Chemoradiotherapy Treatment
por: Ots, Pilar Ma Samper, et al.
Publicado: (2008)

Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity
por: Seidl, Andreas, et al.
Publicado: (2011)

Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients
por: Prasad, Bhanu, et al.
Publicado: (2020)

Surgical prescription of epoetin alfa in contemporary total hip arthroplasty: a prospective comparative study
por: Hourlier, Hervé, et al.
Publicado: (2019)

Successful desensitization therapy for a patient with isoniazid-induced hypersensitivity pneumonia
por: Chihara, Yuichi, et al.
Publicado: (2016)

Phenobarbital-induced anticonvulsant hypersensitivity syndrome in a cat
por: SOHN, Sang-June, et al.
Publicado: (2019)

Efficacy and Safety of Andexanet Alfa for Bleeding Caused by Factor Xa Inhibitors: A Systematic Review and Meta-Analysis
por: Shrestha, Dhan B, et al.
Publicado: (2021)

Immunotherapy Effectiveness in Treating Peanut Hypersensitivity: A Systemic Review
por: Alghamdi, Rahaf, et al.
Publicado: (2022)

Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients
por: Casadevall, Nicole, et al.
Publicado: (2017)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
por: Wilkinson, P M, et al.
Publicado: (2006)

TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients
por: Gaweda, Adam E, et al.
Publicado: (2014)

Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial
por: Moebus, Volker, et al.
Publicado: (2013)

Arterial and venous thrombosis complicating coronary artery bypass grafting after use of epoetin alfa-epbx
por: Murillo-Berlioz, Alejandro, et al.
Publicado: (2020)

Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia
por: Cremieux, Pierre Y., et al.
Publicado: (2004)

Acute Recreational Cannabis-Induced Hypersensitivity Pneumonitis: A Case Report
por: Luke, Nicholas D, et al.
Publicado: (2023)

Metastatic Castrate-Resistant Prostate Cancer: A Rare Cause of Bowel Obstruction
por: Ehsanullah, Syed, et al.
Publicado: (2021)

Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience
por: Sulaiman, Narisa, et al.
Publicado: (2017)

Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type
por: Gelincik, Aslı, et al.
Publicado: (2019)

Successful desensitization in a patient with hypersensitivity to multiple insulin preparations - case report
por: Petricău, Carina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gasdk3a92234dbqs8gs8sobcel